期刊文献+

2型糖尿病合并肾功能不全人群如何合理选择降糖药 被引量:6

Reasonable choice of antidiabetic drugs for patients with diabetes and renal insuffi ciency
下载PDF
导出
摘要 与糖尿病或肾功能不全患者相比,糖尿病合并肾功能不全患者的预后更差,因此应加强对这类患者的规范管理,包括血糖控制。随着肾功能的降低,尤其是当估算肾小球滤过率(estimated glomerular filtration rate,e GFR)<60ml/(min·1.73m2)时,多数降糖药物的药代动力学会发生变化,需要根据肾功能状况选择适当的降糖药并及时调整剂量,以保证有效控制血糖,降低糖尿病并发症发生率,同时最大程度地减少不良反应。
作者 李全民 王秩
出处 《药品评价》 CAS 2015年第3期30-33,共4页 Drug Evaluation
  • 相关文献

参考文献2

二级参考文献49

  • 1全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:700
  • 2陈崴,王辉,董秀清,何惠娟,刘庆华,骆宁,谭嘉庆,林建雄,聂静,毛海萍,陈维清,余学清.广州市城区普通人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2007,23(3):147-151. 被引量:172
  • 3Taal MW, Chertow GM, Marsden PA, el al. Brenner c. Ree tor's The Kidney. 9th ed. Philadelphia, PA= Saunders Elsevi- er, 2012.
  • 4Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China N Engl J Med, 2010,362:1090-1101.
  • 5Fox CS, Larson MG, I.eip EP, et al. Predictors of new-onset kidney disease in a community based population. JAMA,2004, 291 : 84,1-850.
  • 6Zhang 1., Zhang P, Wang F, et al. Prevalence and factors as- sociated with CKD: a population study from Beijing. Am J Kid- ney Dis, 2008, 51:373-384.
  • 7Zhang L, Wang F, Wang L, et al. Prevalence of chronic kid- ney disease in China: a cross sectional survey, Lancei, 2012, 379:815-822.
  • 8National Kidney Foundation. KI)O'QI Clinical practice guide- lines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis, 2007,49(suppl 2): S1 -S180.
  • 9Koro CE, Lee BH, Bowlin SJ. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diahetes mellitus in the United States. Clin Ther, 2009, 31:2608-2617.
  • 10Lu B, Song X, Dong X, et al. High prevalence of chronic kid ney disease in populatiowhased patients diagnosed with type 2 diabetes in downtown Shanghai. J Diabetes Complications, 2008,22:96- 103.

共引文献58

同被引文献33

  • 1胡静,杨世民.论我国建立临床药师制度的难点问题[J].中国药房,2004,15(10):580-582. 被引量:42
  • 2陈海平.肾功能不全对药动学的影响及临床用药原则[J].药物不良反应杂志,2005,7(4):267-271. 被引量:9
  • 3田慧,卢艳慧,龚燕萍.胰岛素促泌剂类药物的临床应用[J].中国医刊,2007,42(10):21-24. 被引量:13
  • 4Masakazu H,Akizuki M. Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how? [J]. Nephrol Dial Transplant, 2009, 24(2): 338-341.
  • 5Lubowsky N D, Siegel R, Pittas.A G, Management of glycemia in patients with diabetes mellitus and CKD [J]. Am J Kidney Dis, 2007, 50(5): 865-879.
  • 6Blech S, Ludwig-Sctiwellinger E, Grafe-Mody E U, et al. The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, iffhumans [J]. Drug Metab Dispos, 2010,38(4): 667-678.
  • 7Charpen~ier G, Riveline J P, Varroud-Vial M. Management of drugs affecting blood glucose in diabetic patients with renal failure [J]. Diabetes Metab, 2000,26 ( Suppl 4 ) : S73-$85.
  • 8Bennett W M, Aronoff G R, Morrison G, et aI.Drug prescribing in renal failure: dosing guidelines for adults [J]. Am J Kidney Dis, 1983, 3(3): 155-193.
  • 9Zhao W, Katzmarzyk P T, Horswell R, et al. Aggressive blood pressure control increases coronary heart disease risk among diabetic patients [J]. Diabetes Care, 2013, 3600): 3287-3296.
  • 10胡瑞钺,田波,喻建勇.托拉塞米的临床应用与比较探讨[J].中国医药导报,2010,7(2):189-190. 被引量:19

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部